SG Americas Securities LLC purchased a new position in Intrexon Corporation (NYSE:XON) during the first quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 8,258 shares of the biotechnology company’s stock, valued at approximately $164,000.
Several other institutional investors also recently bought and sold shares of the company. State Board of Administration of Florida Retirement System raised its position in Intrexon Corporation by 0.9% in the fourth quarter. State Board of Administration of Florida Retirement System now owns 75,606 shares of the biotechnology company’s stock worth $1,837,000 after buying an additional 707 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in Intrexon Corporation by 670.5% in the fourth quarter. Dimensional Fund Advisors LP now owns 83,514 shares of the biotechnology company’s stock valued at $2,029,000 after buying an additional 72,675 shares in the last quarter. GSA Capital Partners LLP acquired a new stake in Intrexon Corporation during the fourth quarter valued at about $232,000. Norges Bank acquired a new stake in Intrexon Corporation during the fourth quarter valued at about $17,300,000. Finally, Teachers Advisors LLC raised its stake in Intrexon Corporation by 6.4% in the fourth quarter. Teachers Advisors LLC now owns 50,172 shares of the biotechnology company’s stock valued at $1,219,000 after buying an additional 3,005 shares in the last quarter. 84.44% of the stock is owned by hedge funds and other institutional investors.
Shares of Intrexon Corporation (NYSE:XON) opened at 24.23 on Monday. The firm’s 50-day moving average price is $23.27 and its 200-day moving average price is $22.60. The stock’s market cap is $2.90 billion. Intrexon Corporation has a 52-week low of $18.41 and a 52-week high of $32.90.
Intrexon Corporation (NYSE:XON) last released its quarterly earnings data on Wednesday, May 10th. The biotechnology company reported ($0.26) EPS for the quarter, missing the consensus estimate of ($0.22) by $0.04. Intrexon Corporation had a negative net margin of 76.32% and a negative return on equity of 21.19%. The company had revenue of $53.70 million for the quarter, compared to the consensus estimate of $49.08 million. During the same period last year, the company earned ($0.55) EPS. The firm’s revenue for the quarter was up 23.7% on a year-over-year basis. Equities analysts predict that Intrexon Corporation will post ($0.92) EPS for the current year.
ILLEGAL ACTIVITY WARNING: This report was published by WKRB News and is owned by of WKRB News. If you are reading this report on another publication, it was illegally copied and republished in violation of United States and international trademark & copyright legislation. The legal version of this report can be viewed at https://www.wkrb13.com/markets/2284362/sg-americas-securities-llc-invests-164000-in-intrexon-corporation-xon.html.
XON has been the subject of several research analyst reports. Wunderlich dropped their price objective on Intrexon Corporation from $50.00 to $35.00 and set a “buy” rating for the company in a research note on Tuesday, March 14th. Stifel Nicolaus reissued a “buy” rating and set a $57.00 price objective on shares of Intrexon Corporation in a research note on Tuesday, April 4th. Zacks Investment Research raised Intrexon Corporation from a “hold” rating to a “buy” rating and set a $24.00 price objective for the company in a research note on Tuesday, May 2nd. Finally, BidaskClub raised Intrexon Corporation from a “strong sell” rating to a “sell” rating in a research note on Thursday, June 15th. Two investment analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of “Buy” and a consensus price target of $40.96.
Intrexon Corporation Company Profile
Intrexon Corporation (Intrexon) forms collaborations to create biologically-based products and processes using synthetic biology. The Company’s domestic operations are in California, Florida, Maryland, and Virginia, and its primary international operations are in Belgium and Hungary. The Company designs, builds and regulates gene programs, which are deoxyribonucleic acid (DNA) sequences that consist of genetic components.
Want to see what other hedge funds are holding XON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intrexon Corporation (NYSE:XON).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2284362/sg-americas-securities-llc-invests-164000-in-intrexon-corporation-xon.html
Receive News & Ratings for Intrexon Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intrexon Corporation and related companies with MarketBeat.com's FREE daily email newsletter.